Synovus Financial Corp Penumbra Inc Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$185.27 - $238.73 $4,261 - $5,490	-23 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$153.32 - $191.72 $2,146 - $2,684	-14 Reduced 37.84%	23 $4,000
Q1 2020 Apr 24, 2020	BUY	$124.34 - $193.76 $1,740 - $2,712	14 Added 60.87%	37 $6,000
Q3 2018 Nov 01, 2018	BUY	$121.55 - $156.8 $2,795 - $3,606	23 New	23 $3,000

427

29.3M

254K

43.3K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $11.1B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.